In August 2022, Novo announced that since its approval in 2021, the weight-loss drug Wegovywhich also uses semaglutide as its main active ingredienthad been met with overwhelming demand. To try to manage the resulting product outages, Novo scaled back its promotions of Wegovy and asked prescribers to avoid starting patients on the treatment
As a member of the NSAID family, ibuprofens mechanism of action hinges on its ability to inhibit the cyclooxygenase (COX) enzymes, COX-1 and COX-2
The tirzepatide in Zepbound mimics two hormones, GLP-1 and GIP
The typical BPC-157 dosage for bodybuilding and athletic recovery is 200-500 mcg daily, administered via subcutaneous injection near the injury site when possible
Menopause brings various health changes driven by shifts in hormones, metabolism, and body composition